azacitidine has been researched along with gsk-2816126 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hattori, N; Takeshima, H; Ushijima, T; Wakabayashi, M; Yamashita, S | 1 |
1 other study(ies) available for azacitidine and gsk-2816126
Article | Year |
---|---|
Identification of coexistence of DNA methylation and H3K27me3 specifically in cancer cells as a promising target for epigenetic therapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Benzamides; Cell Proliferation; Decitabine; DNA Methylation; Enhancer of Zeste Homolog 2 Protein; Enzyme Inhibitors; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; HCT116 Cells; Histone Deacetylase Inhibitors; Histones; Humans; Indoles; Insulin-Like Growth Factor Binding Proteins; Intercellular Signaling Peptides and Proteins; Male; MCF-7 Cells; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Polycomb Repressive Complex 2; Promoter Regions, Genetic; Pyridines; Pyridones; Xenograft Model Antitumor Assays | 2015 |